The relationship between plasminogen activator inhibitor-1 and type 2 diabetes: a systematic review and meta-analysis

James Yarmolinsky; Natália Bordin Barbieri; Tobias Weinmann; Bruce B Duncan; Maria Inês Schmidt

首页> 外文期刊>Diabetology and Metabolic Syndrome >The relationship between plasminogen activator inhibitor-1 and type 2 diabetes: a systematic review and meta-analysis

【24h】

The relationship between plasminogen activator inhibitor-1 and type 2 diabetes: a systematic review and meta-analysis

机译：纤溶酶原激活物抑制剂-1与2型糖尿病的关系：系统评价和荟萃分析

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Diabetology and Metabolic Syndrome》 |2015年第s1期|共页
作者
James Yarmolinsky; Natália Bordin Barbieri; Tobias Weinmann; Bruce B Duncan; Maria Inês Schmidt;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类内分泌腺疾病及代谢病;
关键词

相似文献

外文文献
中文文献
专利

1. Plasminogen activator inhibitor-1 and type 2 diabetes: a systematic review and meta-analysis of observational studies [J] . James Yarmolinsky, Natália Bordin Barbieri, Tobias Weinmann, Scientific reports. . 2016,第1期

机译：纤溶酶原激活物抑制剂-1和2型糖尿病：一种系统审查和荟萃分析观察研究
2. Comparison of plasminogen activator inhibitor-1, tissue type plasminogen activator antigen, fibrinogen, and D-dimer levels in various age decades in patients with type 2 diabetes mellitus and stable coronary artery disease (from the BARI 2D trial). [J] . McBane RD 2nd, Hardison RM, Sobel BE The American Journal of Cardiology . 2010,第1期

机译：比较2型糖尿病和稳定型冠状动脉疾病患者不同年龄数十岁时纤溶酶原激活物抑制剂-1，纤溶酶原激活物抗原，纤维蛋白原和D-二聚体水平（来自BARI 2D试验）。
3. Plasminogen activator inhibitor-1 4G/5G polymorphism and retinopathy risk in type 2 diabetes: a meta-analysis [J] . Tengyue Zhang, Chong Pang, Ningdong Li, BMC Medicine . 2013,第1期

机译：纤溶酶原激活物抑制剂1 4G / 5G多态性与2型糖尿病视网膜病变的风险：一项荟萃分析
4. Impact of Information Technology-Based Interventions for Type 2 Diabetes Mellitus on Glycaemic Control: a Systematic Review and Meta-Analysis [C] . NOUF ALHARBI, NAD A ALSUBKI, SIMON DE LUSIGNAN Medical Informatics in Europe Conference. . 2015

机译：基于信息技术的干预措施对血糖控制2型糖尿病的影响：系统审查和荟萃分析
5. Risk of Any Hypoglycemia with New Antihyperglycemic Agents in Patients with Type 2 Diabetes: A Systematic Review and Meta-analysis [D] . Kamalinia, Sanaz. 2019

机译：患有2型糖尿病患者的新抗血糖药物的任何低血糖症的风险：系统审查和荟萃分析
6. The relationship between plasminogen activator inhibitor-1 and type 2 diabetes: a systematic review and meta-analysis [O] . James Yarmolinsky, Natália Bordin Barbieri, Tobias Weinmann, 2015

机译：纤溶酶原激活物抑制剂-1与2型糖尿病的关系：系统评价和荟萃分析
7. Plasminogen activator inhibitor-1 and type 2 diabetes:a systematic review and meta-analysis of observational studies [O] . Yarmolinsky James, Bordin Barbieri Natália, Weinmann Tobias, 2016

机译：纤溶酶原激活物抑制剂1和2型糖尿病：观察性研究的系统评价和荟萃分析

The relationship between plasminogen activator inhibitor-1 and type 2 diabetes: a systematic review and meta-analysis

著录项

相似文献

相关主题

期刊订阅